Russell Investments Group Ltd. Sells 94,068 Shares of Danaher Corporation $DHR

Russell Investments Group Ltd. reduced its position in Danaher Corporation (NYSE:DHR) by 8.8% in the 3rd quarter, Holdings Channel reports. The firm owned 969,088 shares of the conglomerate’s stock after selling 94,068 shares during the quarter. Russell Investments Group Ltd.’s holdings in Danaher were worth $215,064,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. Eurizon Capital SGR S.p.A. increased its holdings in Danaher by 16.8% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 284,412 shares of the conglomerate’s stock valued at $63,120,000 after buying an additional 41,003 shares during the period. Nan Fung Trinity HK Ltd. raised its stake in shares of Danaher by 150.5% in the 3rd quarter. Nan Fung Trinity HK Ltd. now owns 171,200 shares of the conglomerate’s stock valued at $37,929,000 after buying an additional 102,865 shares in the last quarter. Van Strum & Towne Inc. acquired a new position in shares of Danaher in the 3rd quarter valued at $217,000. Three Bridge Wealth Advisors LLC bought a new position in shares of Danaher during the 3rd quarter worth about $55,000. Finally, Schwallier Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter worth about $229,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity at Danaher

In other news, EVP Gregory Milosevich sold 2,100 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $230.62, for a total value of $484,302.00. Following the transaction, the executive vice president directly owned 22,367 shares of the company’s stock, valued at $5,158,277.54. The trade was a 8.58% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the sale, the chief accounting officer owned 9,107 shares in the company, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 10.80% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages have recently weighed in on DHR. UBS Group reiterated a “buy” rating and set a $260.00 target price on shares of Danaher in a research report on Thursday, October 22nd. Deutsche Bank reissued a “buy” rating and issued a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Stifel Nicolaus raised their price target on shares of Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, October 22nd. Royal Bank Of Canada lifted their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Finally, Guggenheim upped their price objective on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $242.91.

Danaher Trading Down 1.4%

Shares of Danaher stock opened at $232.08 on Friday. The stock has a market capitalization of $163.28 billion, a P/E ratio of 37.98, a price-to-earnings-growth ratio of 2.95 and a beta of 0.76. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The company has a 50-day simple moving average of $222.11 and a 200 day simple moving average of $201.53. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. The firm had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.89 earnings per share. Research analysts expect that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s payout ratio is 26.19%.

Danaher Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.